Tags: anemia | omontys | takeda | recall | peginesatide

Anemia Drug Recalled After Deaths

U.S. Affymax Inc. and Japan's Takeda Pharmaceutical Co said they are voluntarily recalling all lots of anemia treatment Omontys (peginesatide) in the U.S., due to reports of serious hypersensitivity reactions, including some deaths.

As of Sunday, fatal reactions to the injection have been reported in approximately 0.02 percent of 25,000 patients after receiving their initial injection of the treatment, Affymax said in a statement.

Obamacare: Massive New Rules Revealed for 2013

© 2015 Thomson/Reuters. All rights reserved.

1Like our page
2Share
Health-News
U.S. Affymax Inc.and Japan's Takeda Pharmaceutical Co said they are voluntarily recalling all lots of anemia treatment Omontys...
anemia,omontys,takeda,recall,peginesatide
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved